The Sarilumab Injection, cataloged under National Stock Number 6505-01-688-1062, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Regeneron Pharmaceuticals Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-688-1062 |
| Primary Part Number | NDC00024-5910-01 |
| Item Name | Sarilumab Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Regeneron Pharmaceuticals Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00024-5910-01 PRIMARY | Regeneron Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| 1574261 | 5/1 Secondary reference U.S. Government activity |
| KEVZARA | 5/1 Secondary reference Regeneron Pharmaceuticals Inc |
| 6505NCM206232 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-688-1062 is a Sarilumab Injection, manufactured by Regeneron Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-688-1062 has 1 manufacturer part number on file: NDC00024-5910-01 (Regeneron Pharmaceuticals Inc).
Key specifications for NDC00024-5910-01: Special Features: AN INTERLEUKIN-6 (IL-6) RECEPTOR ANTAGONIST INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE DISEASE-MODIFYING ANTIRHEUMATIC DRUGS; INTENDED FOR SUBCUTANEOUS ADMINISTRATION; 200MG/1.14ML SOLUTION IN SINGLE-DOSE PRE-FILLED SYRINGE; INJECTION IS SUPPLIED AS A COLORLESS TO PALE YELLOW SOLUTION; REFRIGERATE AT 36F TO 46F (2C TO 8C) IN ORIGINAL CARTON TO PROTECT FROM LIGHT; DO NOT FREEZE; DO NOT SHAKE; PACKAGE OF 2 SINGLE-DOSE PRE-FILLED SYRINGES EACH CONTAINING 200MG; Part Name Assigned by Controlling Agency: SARILUMAB INJECTION, 2 SINGLE-DOSE PRE-FILLED SYRINGES, 200MG EA. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.